Prothena Corporation plc (NASDAQ: PRTA)’s stock price has gone decline by -6.90 in comparison to its previous close of 21.59, however, the company has experienced a -14.07% decrease in its stock price over the last five trading days. zacks.com reported 2024-05-09 that Prothena (PRTA) posts a wider-than-expected loss in the first quarter on lower revenues and higher costs.
Is It Worth Investing in Prothena Corporation plc (NASDAQ: PRTA) Right Now?
Moreover, the 36-month beta value for PRTA is 0.25. Analysts have varying opinions on the stock, with 7 analysts rating it as a “buy,” 5 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for PRTA is 46.41M and currently, short sellers hold a 14.54% of that float. On May 24, 2024, PRTA’s average trading volume was 549.44K shares.
PRTA’s Market Performance
PRTA’s stock has seen a -14.07% decrease for the week, with a -2.24% drop in the past month and a -26.16% fall in the past quarter. The volatility ratio for the week is 5.75%, and the volatility levels for the past 30 days are at 5.87% for Prothena Corporation plc The simple moving average for the past 20 days is -8.34% for PRTA’s stock, with a -43.87% simple moving average for the past 200 days.
Analysts’ Opinion of PRTA
Many brokerage firms have already submitted their reports for PRTA stocks, with BofA Securities repeating the rating for PRTA by listing it as a “Neutral.” The predicted price for PRTA in the upcoming period, according to BofA Securities is $38 based on the research report published on January 30, 2024 of the current year 2024.
Deutsche Bank, on the other hand, stated in their research note that they expect to see PRTA reach a price target of $62. The rating they have provided for PRTA stocks is “Buy” according to the report published on December 12th, 2023.
SVB Securities gave a rating of “Outperform” to PRTA, setting the target price at $80 in the report published on April 24th of the previous year.
PRTA Trading at -12.76% from the 50-Day Moving Average
After a stumble in the market that brought PRTA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -73.94% of loss for the given period.
Volatility was left at 5.87%, however, over the last 30 days, the volatility rate increased by 5.75%, as shares sank -2.24% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -29.72% lower at present.
During the last 5 trading sessions, PRTA fell by -14.07%, which changed the moving average for the period of 200-days by -67.02% in comparison to the 20-day moving average, which settled at $21.91. In addition, Prothena Corporation plc saw -44.69% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PRTA starting from Walker Karin L, who sale 5,000 shares at the price of $34.00 back on Jan 24 ’24. After this action, Walker Karin L now owns 0 shares of Prothena Corporation plc, valued at $170,000 using the latest closing price.
Walker Karin L, the Chief Accounting Officer of Prothena Corporation plc, sale 5,000 shares at $37.19 during a trade that took place back on Dec 20 ’23, which means that Walker Karin L is holding 0 shares at $185,952 based on the most recent closing price.
Stock Fundamentals for PRTA
Current profitability levels for the company are sitting at:
- -2.42 for the present operating margin
- 0.78 for the gross margin
The net margin for Prothena Corporation plc stands at -1.93. The total capital return value is set at -0.37. Equity return is now at value -31.07, with -25.26 for asset returns.
Based on Prothena Corporation plc (PRTA), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -12.76. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -33.02.
Currently, EBITDA for the company is -190.11 million with net debt to EBITDA at 2.54. When we switch over and look at the enterprise to sales, we see a ratio of 6.13. The liquidity ratio also appears to be rather interesting for investors as it stands at 13.08.
Conclusion
To wrap up, the performance of Prothena Corporation plc (PRTA) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
